Viestenz Arne, Viestenz Anja, Mardin C Y
Augenklinik mit Poliklinik der Universität Erlangen-Nürnberg, Erlangen.
Ophthalmologe. 2003 May;100(5):402-5. doi: 10.1007/s00347-002-0745-3.
A 70-year-old male with optic disc pallor and visual field constriction up to 35 degrees bilaterally was previously treated with vigabatrin. The cumulative dosage was 3.7 kg. The b-wave was reduced in photopic and scotopic electroretinography and the patient had delayed visual evoked potentials. The retinal nerve fiber thickness was pathologically reduced in the Heidelberg retinal tomography (HRT) and the retinal nerve fiber layer analyzer (GDx).
Vigabatrin is an antiepileptic drug and may increase the intraretinal GABA level due to an inhibition of the enzyme GABA-transaminase and may induce an ascending simple optic nerve atrophy. Vigabatrin-associated visual field defects may be irreversible. A visual field control is recommended before starting the treatment with vigabatrin and at regular 6-month intervals thereafter. In cases of visual field constriction, the therapy should be stopped. If the cumulative dosage is more than 3 kg of vigabatrin, the visual field controls should be performed more frequently because of the dosage-toxicity relationship.
一名70岁男性,双侧视盘苍白且视野缩窄达35度,此前接受过vigabatrin治疗。累积剂量为3.7千克。明视和暗视视网膜电图中b波降低,患者视觉诱发电位延迟。海德堡视网膜断层扫描(HRT)和视网膜神经纤维层分析仪(GDx)显示视网膜神经纤维厚度病理性降低。
Vigabatrin是一种抗癫痫药物,可能因抑制γ-氨基丁酸转氨酶而增加视网膜内γ-氨基丁酸水平,并可能导致上行性单纯性视神经萎缩。Vigabatrin相关的视野缺损可能是不可逆的。建议在开始使用vigabatrin治疗前及之后每6个月定期进行一次视野检查。出现视野缩窄时,应停止治疗。如果vigabatrin累积剂量超过3千克,由于剂量-毒性关系,应更频繁地进行视野检查。